1-7 of 7
William Tong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Clinical Trial of the Sequential Combination of Irinotecan Followed by Flavopiridol

Manish A. Shah, Jeremy Kortmansky, Monica Motwani, Marija Drobnjak, Mithat Gonen, Sandy Yi, Amanda Weyerbacher, Carlos Cordon-Cardo, Robert Lefkowitz, Baruch Brenner, Eileen O'Reilly, Leonard Saltz, William Tong, David P. Kelsen, Gary K. Schwartz
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (10): 3836–3845.
https://doi.org/10.1158/1078-0432.CCR-04-2651
Published: 16 May 2005
View article titled, A Phase I Clinical Trial of the Sequential Combination of Irinotecan Followed by Flavopiridol
Open the PDF for A Phase I Clinical Trial of the Sequential Combination of Irinotecan Followed by Flavopiridol in another window
Journal Articles

Phase I Clinical Trial of Histone Deacetylase Inhibitor: Suberoylanilide Hydroxamic Acid Administered Intravenously

Wm. Kevin Kelly, Victoria M. Richon, Owen O’Connor, Tracy Curley, Barbara MacGregor-Curtelli, William Tong, Mark Klang, Lawrence Schwartz, Stacie Richardson, Eddie Rosa, Marija Drobnjak, Carlos Cordon-Cordo, Judy H. Chiao, Richard Rifkind, Paul A. Marks, Howard Scher
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3578–3588.
Published: 23 September 2003
View article titled, Phase I Clinical Trial of Histone Deacetylase Inhibitor: <subtitle>Suberoylanilide Hydroxamic Acid Administered Intravenously</subtitle>
Open the PDF for Phase I Clinical Trial of Histone Deacetylase Inhibitor: <subtitle>Suberoylanilide Hydroxamic Acid Administered Intravenously</subtitle> in another window
Journal Articles

Dose Escalation Study of Intravenous Estramustine Phosphate in Combination with Paclitaxel and Carboplatin in Patients with Advanced Prostate Cancer

William Kevin Kelly, Andrew X. Zhu, Howard Scher, Tracey Curley, Mary Fallon, Susan Slovin, Lawrence Schwartz, Steve Larson, William Tong, Beryl Hartley-Asp, Cinzia Pellizzoni, Maurizio Rocchetti
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (6): 2098–2107.
Published: 01 June 2003
View article titled, Dose Escalation Study of Intravenous Estramustine Phosphate in Combination with Paclitaxel and Carboplatin in Patients with Advanced Prostate Cancer
Open the PDF for Dose Escalation Study of Intravenous Estramustine Phosphate in Combination with Paclitaxel and Carboplatin in Patients with Advanced Prostate Cancer in another window
Journal Articles

10-Propargyl-10-deazaaminopterin: An Antifolate with Activity in Patients with Previously Treated Non-Small Cell Lung Cancer

Lee M. Krug, Christopher G. Azzoli, Mark G. Kris, Vincent A. Miller, Nushmia Z. Khokhar, William Tong, Michelle S. Ginsberg, Ennapadam Venkatraman, Leslie Tyson, Barbara Pizzo, Valerie Baez, Kenneth K. Ng, F. M. Sirotnak
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (6): 2072–2078.
Published: 01 June 2003
View article titled, 10-Propargyl-10-deazaaminopterin: <subtitle>An Antifolate with Activity in Patients with Previously Treated Non-Small Cell Lung Cancer</subtitle>
Open the PDF for 10-Propargyl-10-deazaaminopterin: <subtitle>An Antifolate with Activity in Patients with Previously Treated Non-Small Cell Lung Cancer</subtitle> in another window
Journal Articles

17-Allylamino-17-demethoxygeldanamycin Induces the Degradation of Androgen Receptor and HER-2/ neu and Inhibits the Growth of Prostate Cancer Xenografts

David B. Solit, Fuzhong F. Zheng, Maria Drobnjak, Pamela N. Münster, Brian Higgins, David Verbel, Glenn Heller, William Tong, Carlos Cordon-Cardo, David B. Agus, Howard I. Scher, Neal Rosen
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (5): 986–993.
Published: 01 May 2002
View article titled, 17-Allylamino-17-demethoxygeldanamycin Induces the Degradation of Androgen Receptor and HER-2/ <em>neu</em> and Inhibits the Growth of Prostate Cancer Xenografts
Open the PDF for 17-Allylamino-17-demethoxygeldanamycin Induces the Degradation of Androgen Receptor and HER-2/ <em>neu</em> and Inhibits the Growth of Prostate Cancer Xenografts in another window
Journal Articles

Phase I and Pharmacokinetic Study of 10-Propargyl-10-deazaaminopterin, a New Antifolate

Lee M. Krug, Kenneth K. Ng, Mark G. Kris, Vincent A. Miller, William Tong, Robert T. Heelan, Larry Leon, Denis Leung, Jean Kelly, F. M. Sirotnak
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (9): 3493–3498.
Published: 01 September 2000
View article titled, Phase I and Pharmacokinetic Study of 10-Propargyl-10-deazaaminopterin, a New Antifolate
Open the PDF for Phase I and Pharmacokinetic Study of 10-Propargyl-10-deazaaminopterin, a New Antifolate in another window
Journal Articles

Toxicology and Pharmacokinetics of Intravesical Gemcitabine: A Preclinical Study in Dogs

Paul J. Cozzi, Dean F. Bajorin, William Tong, Hai Nguyen, Joe Scott, Warren D. W. Heston, Guido Dalbagni
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (9): 2629–2637.
Published: 01 September 1999
View article titled, Toxicology and Pharmacokinetics of Intravesical Gemcitabine: A Preclinical Study in Dogs
Open the PDF for Toxicology and Pharmacokinetics of Intravesical Gemcitabine: A Preclinical Study in Dogs in another window